4,4′-DMAR in-vivo acute cardiotoxicity: differences between (±)cis-4,4′-DMAR and its coadministration with the (±)trans-4,4′-DMAR isomer - Poll - MDSpire

4,4′-DMAR in-vivo acute cardiotoxicity: differences between (±)cis-4,4′-DMAR and its coadministration with the (±)trans-4,4′-DMAR isomer

  • By

  • Giorgia Corli

  • Elisa Roda

  • Beatrice Marchetti

  • Micaela Tirri

  • Sabrine Bilel

  • Marta Bassi

  • Beatrice Benedetti

  • Elena Cavarretta

  • Giacomo Frati

  • Fabrizio De Luca

  • Carlo Alessandro Locatelli

  • Fabio De-Giorgio

  • Matteo Marti

  • June 16, 2026

  • 0 min

Share

Original Source(s)

4,4′-DMAR in-vivo acute cardiotoxicity: differences between (±)cis-4,4′-DMAR and its coadministration with the (±)trans-4,4′-DMAR isomer

  • by Giorgia Corli, Elisa Roda, Beatrice Marchetti, Micaela Tirri, Sabrine Bilel, Marta Bassi, Beatrice Benedetti, Elena Cavarretta, Giacomo Frati, Fabrizio De Luca, Carlo Alessandro Locatelli, Fabio De-Giorgio, Matteo Marti

  • June 16, 2026

Related Content

Could gene editing offer the one-time fix for artery-clogging cholesterol?

Top 10 Evidence-Based Essentials in Cardiology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

Psychosocial Impact on Cardiac Patients: A Retrospective Analysis of In-Hospital Data